Kisspeptin
A neuropeptide that sits at the top of your reproductive hormone cascade. Kisspeptin tells your brain to start producing the hormones that drive fertility, puberty, and sexual function — and it's being studied as a potential fertility treatment.
Kisspeptin is the master switch for your reproductive axis. It signals your hypothalamus to release GnRH (gonadotropin-releasing hormone), which then triggers LH and FSH — the hormones that drive testosterone, estrogen, and fertility. Clinical trials have tested it for IVF protocols and hypogonadism.
Who's interested: People with hypothalamic amenorrhea, those exploring alternatives to HCG for fertility, researchers studying puberty disorders, and men interested in natural testosterone axis stimulation.
Dive deeper into the researchPotential side effects
- Flushing and warmth (common with IV administration)
- Mild nausea reported in some clinical studies
- Short duration of action — effects last hours, not days
What does kisspeptin do?
Your reproductive hormone system works like a cascade: the hypothalamus signals the pituitary, which signals the gonads. Kisspeptin sits at the very top of this cascade — it's what tells your hypothalamus to release GnRH in the first place.
Without kisspeptin signaling, puberty doesn't happen. In adults, kisspeptin dysfunction can cause hypothalamic amenorrhea (loss of periods from stress or low body weight) and hypogonadotropic hypogonadism (low sex hormones due to insufficient brain signaling).
Who uses it?
- Fertility research — tested as a trigger for egg maturation in IVF, potentially safer than HCG
- Hypothalamic amenorrhea — restores pulsatile GnRH release in women who've lost their periods
- HPG axis assessment — used diagnostically to test if the hypothalamic-pituitary-gonadal axis is intact
- Sexual function — early research suggests kisspeptin may enhance sexual arousal and desire
What to know before trying
Kisspeptin has legitimate clinical research behind it — particularly for fertility. However, it's not yet approved as a drug anywhere. Its very short half-life (minutes to hours) makes it impractical for chronic self-administration.
- Very short half-life — effects last minutes (IV) to hours (subcutaneous), limiting practical use
- Stimulates natural production — unlike TRT or HCG, kisspeptin works through your body's own signaling cascade
- Dose-dependent effects — too much continuous kisspeptin actually desensitises the receptor, reducing hormone output
- Research setting preferred — most human data is from controlled clinical environments
Tracking a peptide protocol?
eterni connects your labs, supplements, and retests — so you can see whether your protocol is actually working.
Get early accessFrequently Asked Questions
What is kisspeptin used for?
Kisspeptin is being studied as a fertility treatment (especially for IVF egg maturation trigger), a diagnostic tool for reproductive hormone disorders, and a potential treatment for hypothalamic amenorrhea. It naturally triggers your brain's reproductive hormone cascade.
Can kisspeptin boost testosterone?
In healthy men, kisspeptin injection acutely increases LH and testosterone levels. However, the effect is short-lived (hours), and chronic administration may actually desensitise the receptor. It is not a practical testosterone-boosting strategy compared to other interventions.
Is kisspeptin available in India?
Kisspeptin is available as a research peptide from specialty vendors. It is not approved as a drug in India. Clinical-grade kisspeptin is limited to research settings.
How does kisspeptin differ from HCG?
HCG directly mimics LH at the gonadal level. Kisspeptin works upstream — at the hypothalamic level — triggering natural GnRH release, which then stimulates natural LH and FSH production. Kisspeptin preserves the entire cascade; HCG bypasses most of it.
How it works in your body
- Hypothalamic signaling — kisspeptin neurons in the hypothalamus fire to trigger GnRH pulse generation
- GnRH cascade — GnRH pulses stimulate the anterior pituitary to release LH and FSH
- Gonadal stimulation — LH drives testosterone (men) and ovulation (women); FSH drives sperm and follicle development
- Puberty gating — kisspeptin system activation is what initiates puberty
Clinical evidence
- IVF trigger: Non-inferior to HCG for oocyte maturation with lower OHSS risk in some trials
- Hypothalamic amenorrhea: Restored LH pulsatility in women with stress-related amenorrhea
- Sexual function: fMRI studies showed increased brain activity in sexual arousal centers after kisspeptin administration
- Diagnostic use: Kisspeptin challenge tests can differentiate causes of hypogonadism
Side effects & safety
- Flushing/warmth — the most commonly reported effect, especially with IV dosing
- Nausea — mild, transient in clinical studies
- Receptor desensitisation — continuous exposure paradoxically suppresses reproductive hormones (like GnRH agonist drugs)
- Short duration — not really a side effect, but the brief action window limits usefulness
Who should avoid it: People with hormone-sensitive cancers, pregnant women, and anyone without medical supervision for hormone manipulation.
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist